Sign up

Rock Springs Capital Management LP

$2.0B assets · 104 holdings · Q2 2026 · Filed 14 AUG 2026

About Rock Springs Capital Management LP’s 13F portfolio

Rock Springs Capital Management LP is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Rock Springs Capital Management LP reported $2.0B across 104 US-listed positions (). Its largest position is REVOLUTION MEDICINES INC (RVMD) at 10% of the reported book, and its ten biggest holdings make up 44% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.

$2.0B
Assets (13F)
#1,461
of 8,845 by size
104
Holdings
44%
Top-10 weight
57
Buys
43
Sells
Top holdings · Q2 2026
104 total
#StockPrice% of portfolioSharesValue
1
NASDAQ: RVMD
REVOLUTION MEDICINES INC
$159.43
−0.24%
10%
1.1M$207.0M
2
NASDAQ: TVTX
TRAVERE THERAPEUTICS INC
$48.30
−3.86%
6.0%
2.2M$123.8M
3
NYSE: LLY
ELI LILLY & CO
$1,351.12
−2.29%
5.8%
99K$118.4M
4
NASDAQ: MDGL
MADRIGAL PHARMACEUTICALS INC
$396.74
−0.34%
4.6%
175K$94.0M
5
NASDAQ: MIRM
MIRUM PHARMACEUTICALS INC
$95.51
+3.27%
4.6%
798K$93.4M
6
NASDAQ: RYTM
RHYTHM PHARMACEUTICALS INC
$116.80
−1.88%
3.8%
693K$76.9M
7
NASDAQ: KYMR
KYMERA THERAPEUTICS INC
$119.39
−1.44%
2.5%
453K$52.0M
8
NASDAQ: ARGX
ARGENX SE
$942.04
+0.08%
2.4%
53K$48.9M
9
NASDAQ: ASND
ASCENDIS PHARMA A/S
$255.96
−5.32%
2.2%
169K$45.0M
10
NASDAQ: XENE
XENON PHARMACEUTICALS INC
$37.56
−0.50%
2.0%
684K$41.3M
11
NASDAQ: SRRK
SCHOLAR ROCK HLDG CORP
$50.37
+4.94%
1.9%
715K$39.3M
12
NASDAQ: INSM
INSMED INC
$144.46
+20.58%
1.9%
362K$38.6M
13
NYSE: PEN
PENUMBRA INC
$320.01
−0.18%
1.8%
116K$36.5M
14
NASDAQ: GPCR
STRUCTURE THERAPEUTICS INC
$17.12
−1.38%
1.7%
640K$34.4M
15
NASDAQ: RARE
ULTRAGENYX PHARMACEUTICAL IN
$17.22
−2.88%
1.6%
968K$32.3M
16
NASDAQ: IRTC
IRHYTHM HOLDINGS INC
$94.24
−0.66%
1.6%
270K$32.1M
17
NASDAQ: ISRG
INTUITIVE SURGICAL INC
$407.24
−3.26%
1.5%
76K$30.4M
18
NYSE: AGL
AGILON HEALTH INC
$89.50
−1.14%
1.4%
263K$28.1M
19
NYSE: UNH
UNITEDHEALTH GROUP INC
$330.48
−5.55%
1.3%
64K$26.5M
20
NASDAQ: CLDX
CELLDEX THERAPEUTICS INC NEW
$27.96
+1.49%
1.3%
699K$26.0M
21
NASDAQ: ERAS
ERASCA INC
$14.22
+3.34%
1.3%
1.4M$25.7M
22
NASDAQ: NBIX
NEUROCRINE BIOSCIENCES INC
$156.59
−3.85%
1.2%
145K$24.4M
23
NASDAQ: ELVN
ENLIVEN THERAPEUTICS INC
$46.41
+3.39%
1.2%
465K$23.6M
24
NYSE: THC
TENET HEALTHCARE CORP
$263.59
−2.86%
1.1%
125K$23.4M
25
NASDAQ: DXCM
DEXCOM INC
$80.19
−2.82%
1.1%
343K$23.1M

Showing 1–25 of 104 positions on this page reported in this 13F.

Sector allocation
  • Healthcare95%
Recent activity · vs 2026-03-31
Bought57
  • AddedTVTXTRAVERE THERAPEUTICS INC+47.4%$123.8M
  • AddedMDGLMADRIGAL PHARMACEUTICALS INC+2.3%$94.0M
  • AddedRYTMRHYTHM PHARMACEUTICALS INC+0.4%$76.9M
  • NewASNDASCENDIS PHARMA A/S—$45.0M
  • AddedINSMINSMED INC+15.2%$38.6M
  • AddedGPCRSTRUCTURE THERAPEUTICS INC+0.0%$34.4M
  • AddedIRTCIRHYTHM HOLDINGS INC+3.0%$32.1M
  • AddedAGLAGILON HEALTH INC+1.0%$28.1M
  • AddedUNHUNITEDHEALTH GROUP INC+20.3%$26.5M
  • AddedCLDXCELLDEX THERAPEUTICS INC NEW+7.5%$26.0M
Sold43
  • ReducedRVMDREVOLUTION MEDICINES INC−8.6%$207.0M
  • ReducedMIRMMIRUM PHARMACEUTICALS INC−1.6%$93.4M
  • ReducedKYMRKYMERA THERAPEUTICS INC−8.8%$52.0M
  • ReducedARGXARGENX SE−46.4%$48.9M
  • ReducedXENEXENON PHARMACEUTICALS INC−10.4%$41.3M
  • ReducedSRRKSCHOLAR ROCK HLDG CORP−3.3%$39.3M
  • ReducedPENPENUMBRA INC−3.9%$36.5M
  • ReducedRAREULTRAGENYX PHARMACEUTICAL IN−20.6%$32.3M
  • ReducedISRGINTUITIVE SURGICAL INC−6.8%$30.4M
  • ReducedNBIXNEUROCRINE BIOSCIENCES INC−3.8%$24.4M

Reading Rock Springs Capital Management LP’s 13F portfolio

Rock Springs Capital Management LP’s $2.0B 13F book is spread across 104 reported positions and is concentrated toward its biggest ideas, with the top ten holdings at 44%. The largest positions carry real weight, so how those names perform matters a lot to the overall book. Its five largest positions are RVMD, TVTX, LLY, MDGL and MIRM, led by REVOLUTION MEDICINES INC (RVMD) at 10% of the portfolio. The heaviest sector exposure is Healthcare (95%).

What Rock Springs Capital Management LP changed last quarter

Between 2026-03-31 and Q2 2026, Rock Springs Capital Management LP was a net buyer: it opened 17 new positions and added to 40 more, while trimming 30 and closing 13 outright. Against a 104-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was TRAVERE THERAPEUTICS INC (TVTX), and its biggest reduction was REVOLUTION MEDICINES INC (RVMD).

What a 13F does and doesn’t reveal

A 13F captures only Rock Springs Capital Management LP’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Rock Springs Capital Management LP is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.

Frequently asked questions

What is an SEC 13F filing?

A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Rock Springs Capital Management LP's profile on this page is built directly from those filings.

How current is the 13F data on Rock Springs Capital Management LP's page?

It reflects Rock Springs Capital Management LP's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Rock Springs Capital Management LP files its next quarterly report, this page refreshes automatically.

Can I see Rock Springs Capital Management LP's complete list of holdings?

This page highlights Rock Springs Capital Management LP's largest positions rather than all 104 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Rock Springs Capital Management LP's filings.

Does a 13F show everything Rock Springs Capital Management LP owns?

No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Rock Springs Capital Management LP's book rather than its full strategy or total assets.

Is 13F data investment advice?

No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Rock Springs Capital Management LP made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.

Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.